Leading Growth Driver in the Arthritic Therapeutic Market in 2025: Increasing Incidence Of Arthritis Is Driving The Growth Of The Arthritic Therapeutic Market Driver's Influence

What Are the Market Size and Growth Forecast for the Arthritic Therapeutic Market?
There has been robust growth in the size of the arthritic therapeutic market in recent years. From 2024 to 2025, it is projected to expand from $68.1 billion to $72.44 billion, representing a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this growth during the historic period are an increase in diagnosed patients, greater awareness of symptoms, a rising incidence of obesity, enhanced diagnostic capabilities and better treatment results.

The market size for arthritis therapy is projected to experience robust growth in the upcoming years, ballooning to $91.72 billion by 2029 at a compound annual growth rate (CAGR) of 6.1%. This increase in the forecast period can be credited to elements such as the enhancement of healthcare infrastructure, governmental undertakings, enabling regulatory structures, attention on bespoke medicine, and a migration towards healthcare tactics centered around the patient. Key trends observed during the forecast period will encompass a focus on biosimilars, a shift of paradigm towards biologics, greater accessibility of biosimilars, a preference for the parenteral route, and the advancement of online pharmacies.

What Is Contributing to the Growth of the Arthritic Therapeutic Market?
The escalating occurrence of arthritis is projected to fuel the expansion of the arthritic therapeutic market in the future. Arthritis encapsulates a diverse array of over 100 conditions primarily marked by joint discomfort and inflammation. Factors such as an expanding aging populace, rising obesity rates and lifestyle elements that trigger joint stress and inflammation, contribute to the growing incidence of arthritis. Therapies for arthritis ease the symptoms, diminish inflammation, and enhance joint functionality, thus improving the overall life quality of the afflicted individuals. As per a June 2024 report from the Australian Institute of Health and Welfare, a governmental agency based in Australia, around 514,000 people, accounting for 2.0% of the population, were grappling with rheumatoid arthritis in 2022. Rheumatoid arthritis accounted for 2.0% of the overall disease burden and made up 16% of the entire burden for all musculoskeletal conditions in 2023. Consequently, the escalating prevalence of arthritis is a significant factor propelling the growth of the arthritic therapeutic market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19297&type=smp

Which Key Market Leaders Are Driving Arthritic Therapeutic Industry Growth?
Major companies operating in the arthritic therapeutic market are Pfizer Inc., Johnson & Johnson, Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Pharma AB, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., UCB Pharma S.A., Incyte Corporation, Celltrion Inc., Mallinckrodt Pharmaceuticals, Genentech Inc., Anika Therapeutics Inc., Medac GmbH

What Are the Emerging Trends in the Arthritic Therapeutic Industry?
Major players in the arthritis treatment market are striving to innovate by crafting solutions like biosimilar monoclonal antibody-based therapies, with the aim of improving treatment effectiveness and cutting expenses. These treatments are carefully engineered to emulate the efficacy of the original monoclonal antibodies, promising comparable therapeutic outcomes at possibly lower prices. Bio-Thera Solutions Ltd., based in China, for example, debuted TOFIDENCE, a biosimilar monoclonal antibody formula based on ACTEMRA in May 2024. TOFIDENCE (tocilizumab-bavi) is positioned as a biosimilar to ACTEMRA, the reference drug, and has gained approval for use in treating moderate to severe rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, and systemic juvenile idiopathic arthritis.

What Are the Main Segments in the Arthritic Therapeutic Market?
The arthritic therapeuticmarket covered in this report is segmented -

1) By Drug Class: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Xanthine Oxidase Inhibitors, Other Drug Classes
2) By Route Of Administration: Oral, Parenteral, Topical
3) By Type: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, Gout, Other Types
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab, Etanercept, Infliximab, Certolizumab Pegol, Golimumab
2) By Interleukin Inhibitors: Interleukin-6 (IL-6) Inhibitors, Interleukin-1 (IL-1) Inhibitors, Interleukin-17 (IL-17) Inhibitors, Interleukin-23 (IL-23) Inhibitors
3) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Meloxicam
4) By Corticosteroids: Prednisone, Methylprednisolone, Hydrocortisone, Dexamethasone
5) By Xanthine Oxidase Inhibitors: Allopurinol, Febuxostat
6) By Other Drug Classes: Disease-Modifying Antirheumatic Drugs (DMARDs), Janus Kinase (JAK) Inhibitors, Biologic DMARDs, Topical Analgesics, Opioid Pain Medications

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/arthritic-therapeutic-global-market-report

Which Geographic Area Leads the Arthritic Therapeutic Market?
North America was the largest region in the arthritic therapeutic market in 2024. The regions covered in the arthritic therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Arthritic Therapeutic Global Market Report?

- Market Size Analysis: Analyze the Arthritic Therapeutic Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Arthritic Therapeutic Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Arthritic Therapeutic Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Arthritic Therapeutic Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19297

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.